Experienced in Hepatic Venoocclusive Disease with Immunodeficiency

Munci A. Yagcı

Gazi, TR 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Hepatic Venoocclusive Disease with Immunodeficiency
Gazi, TR 
OverviewLocationsClinical Research

Overview

Munci Yagcı practices in Gazi, Turkey. Yagcı is rated as an Experienced expert by MediFind in the treatment of Hepatic Venoocclusive Disease with Immunodeficiency. Their top areas of expertise are Multiple Myeloma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Bone Marrow Transplant.

Their clinical research consists of co-authoring 71 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Hepatic Venoocclusive Disease with Immunodeficiency.

Locations

Gazi, Turkey
Other Locations
Besevler, 06500, Turkey
Gazi, Turkey
Besevler, Turkey
Malatya, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3 Multinational, Multi-center, Single-arm, Open-label Study for the Efficacy and Safety of Radotinib in Ph+ Chronic Phase Chronic Myeloid Leukemia Patients With Failure or Intolerance to Previous TKIs Therapy Including Imatinib
A Phase 3 Multinational, Multi-center, Single-arm, Open-label Study for the Efficacy and Safety of Radotinib in Ph+ Chronic Phase Chronic Myeloid Leukemia Patients With Failure or Intolerance to Previous TKIs Therapy Including Imatinib
Enrollment Status: Recruiting
Publish Date: October 28, 2024
Intervention Type: Drug
Study Drug: Radotinib HCl
Study Phase: Phase 3

71 Total Publications

Clinical Manifestations, Treatment Characteristics and Clinical Outcome in Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP) in the Real-World Setting: An Interim Analysis of the Turkish iTTP Registry
Clinical Manifestations, Treatment Characteristics and Clinical Outcome in Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP) in the Real-World Setting: An Interim Analysis of the Turkish iTTP Registry
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: July 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yagcı's expertise for a condition
ConditionClose
      View All 19 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile